The FDA Modernization Act 2.0: Drug Testing in Animals is Rendered Optional

被引：43

作者：

Adashi, Eli Y. ^{[1
,4
]}

O'Mahony, Daniel P. ^{[2
]}

Cohen, I. Glenn ^{[3
]}

机构：

[1] Brown Univ, Dept Med & Biol Sci, Providence, RI USA

[2] Brown Univ Lib, Lib Planning & Assessment, Providence, RI USA

[3] Harvard Univ, Petrie Flom Ctr Hlth Law Policy Biotechnol & Bioet, Harvard Law Sch, Cambridge, MA USA

[4] Brown Univ, Med & Biol Sci, 222 Richmond St, Providence, RI 02903 USA

来源：

AMERICAN JOURNAL OF MEDICINE | 2023年 / 136卷 / 09期

关键词：

D O I：

10.1016/j.amjmed.2023.03.033

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：853 / 854

页数：2

共 5 条

[1]

[Anonymous], 2023, CONGRESS.GOV. H.R.1024 HEARTS Act of 2022. To amend the Public Health Service Act to ensure that nonanimal methods are prioritized, where applicable and feasible, in proposals for all research to be conducted or supported by the National Institutes of Health, to provide for the establishment of the National Center for Alternatives to Animals in Research and Testing, and for other purposes

[2]

[Anonymous], 2021, CONGRESS. GOV. S.2100 - Personal Care Products Safety Act. SEC. 109. Sense of the Senate on Animal testing

[3]

[Anonymous], 2022, CONGRESS.GOV. H.R.2617 - Consolidated Appropriations Act, 2023. Became Public Law No: 117-328

[4]

Authenticated US Government Information (GPO), 1998, 105 C PREPARED STATE

[5]

U.S. Food & Drug Administration, 2022, Advancing alternative methods at FDA

← 1 →